<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Aging (Albany NY)</journal-id><journal-id journal-id-type="iso-abbrev">Aging (Albany NY)</journal-id><journal-id journal-id-type="publisher-id">Aging</journal-id><journal-title-group><journal-title>Aging (Albany NY)</journal-title></journal-title-group><issn pub-type="epub">1945-4589</issn><publisher><publisher-name>Impact Journals</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5892700</article-id><article-id pub-id-type="pmid">29615537</article-id><article-id pub-id-type="publisher-id">101407</article-id><article-id pub-id-type="doi">10.18632/aging.101407</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Strong impact of natural-selection&#8211;free heterogeneity in genetics of age-related phenotypes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kulminski</surname><given-names>Alexander M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Loika</surname><given-names>Yury</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Arbeev</surname><given-names>Konstantin G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bagley</surname><given-names>Olivia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yashkin</surname><given-names>Arseniy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Duan</surname><given-names>Matt</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Culminskaya</surname><given-names>Irina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Biodemography of Aging Research Unit, Social Science Research Institute, <institution>Duke University</institution>, <addr-line><city>Durham</city>, <state>NC</state> 27708</addr-line>, <country>USA</country></aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence to: </bold> Alexander M. Kulminski; <bold>email: </bold><email xlink:href="Alexander.Kulminski@duke.edu">Alexander.Kulminski@duke.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>29</day><month>3</month><year>2018</year></pub-date><volume>10</volume><issue>3</issue><fpage>492</fpage><lpage>514</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#169; 2018 Kulminski et al.</copyright-statement><license specific-use="CC BY 3.0" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>A conceptual difficulty in genetics of age-related phenotypes that make individuals vulnerable to disease in post-reproductive life is genetic heterogeneity attributed to an undefined role of evolution in establishing their molecular mechanisms. Here, we performed univariate and pleiotropic genome-wide meta-analyses of 20 age-related phenotypes leveraging longitudinal information in a sample of 33,431 individuals and dealing with the natural-selection&#8211;free genetic heterogeneity. We identified 142 non-proxy single nucleotide polymorphisms (SNPs) with phenotype-specific (18 SNPs) and pleiotropic (124 SNPs) associations at genome-wide level. Univariate meta-analysis identified two novel (11.1%) and replicated 16 SNPs whereas pleiotropic meta-analysis identified 115 novel (92.7%) and nine replicated SNPs. Pleiotropic associations for most novel (93.9%) and all replicated SNPs were strongly impacted by the natural-selection&#8211;free genetic heterogeneity in its unconventional form of antagonistic heterogeneity, implying antagonistic directions of genetic effects for directly correlated phenotypes. Our results show that the common genome-wide approach is well adapted to handle homogeneous univariate associations within Mendelian framework whereas most associations with age-related phenotypes are more complex and well beyond that framework. Dissecting the natural-selection&#8211;free genetic heterogeneity is critical for gaining insights into genetics of age-related phenotypes and has substantial and unexplored yet potential for improving efficiency of genome-wide analysis.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>genome-wide association studies</kwd><kwd>pleiotropy</kwd><kwd>age-related phenotypes</kwd><kwd>antagonistic genetic heterogeneity</kwd><kwd>aging</kwd><kwd>health span</kwd><kwd>life span</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Genome-wide association studies (GWAS) are a powerful tool for hypothesis-free analysis of genetic predisposition to various phenotypes. Historically, GWAS were built within the &#8220;common disease &#8211; common genetic variant&#8221; concept following the framework of medical genetics. The underlying hypothesis in this framework is that there is a &#8220;true&#8221; or causal genetic effect on a phenotype of interest [<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]. This approach in GWAS has been supported by successful discovery of causal genetic mutations for Mendelian disorders [<xref rid="r3" ref-type="bibr">3</xref>]. Essentially the same approach is pursued in GWAS of complex phenotypes, which do not follow clear pattern of Mendelian inheritance [<xref rid="r4" ref-type="bibr">4</xref>]. Extension of the framework of medical genetics of hereditary disorders to the complex non-Mendelian phenotypes relies on the hypothesis that they can have a genetic component. This hypothesis is supported by the concept of heritability, with significant heritability interpreted as indication of &#8220;pure&#8221; or &#8220;true&#8221; genetic component in a trait [<xref rid="r2" ref-type="bibr">2</xref>]. The concept of heritability, introduced in breeding experiments to improve crop yield, requires, however, controlled and fixed environment [<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>] that is strongly violated in human populations.</p><p>The problem becomes even more challenging for age-related phenotypes, i.e., phenotypes that make individuals vulnerable to disease in post-reproductive life. A conceptual difficulty in genetics of age-related phenotypes is the natural-selection&#8211;free genetic heterogeneity attributed to an undefined role of evolution in establishing their molecular mechanisms [<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>]. This problem is complicated by recent changes in human life expectancy [<xref rid="r9" ref-type="bibr">9</xref>] and the fitness landscape [<xref rid="r10" ref-type="bibr">10</xref>-<xref rid="r13" ref-type="bibr">13</xref>]. Accordingly, in evolutionary biology, age-related phenotypes are viewed as the results of <italic>indirect</italic> mechanisms (&#8220;side effects&#8221;) such as co-evolution with fast-evolving pathogens, mismatch with environments, reproductive success at the expense of health, trade-offs that leave every trait suboptimal, defenses and their special costs, etc [<xref rid="r7" ref-type="bibr">7</xref>]. The concept of heritability in the evolutionary framework for age-related phenotypes becomes even more problematic because the estimates of heritability change as environment changes [<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>] and significant heritability does not imply that the same genetic variant carry the same risk in different population groups, even of the same ancestry [<xref rid="r11" ref-type="bibr">11</xref>].</p><p>The natural-selection&#8211;free genetic heterogeneity has not been addressed in mainstream GWAS. This heterogeneity implies that differences in genetic predisposition to age-related phenotypes across different population groups is biologically motivated. Accordingly, different, even antagonistic, effects of the same allele on the same phenotype in different population groups are biologically plausible [<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>]. Another challenge in the evolutionary framework is that genetic variants predisposing to a phenotype may not necessarily predispose to another, even causally related, phenotype [<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>] or such genetic variants can predispose to seemingly unrelated phenotypes [<xref rid="r18" ref-type="bibr">18</xref>-<xref rid="r20" ref-type="bibr">20</xref>].</p><p>Here, we examine genetic predisposition to age-related phenotypes following the concept of an undefined role of evolution in establishing their molecular mechanisms. We performed the univariate and pleiotropic GWAS meta-analyses of 20 age-related phenotypes in the sample of 33,431 Caucasians from five longitudinal studies. We identified 142 non-proxy (defined as linkage disequilibrium [LD] <italic>r<sup>2</sup></italic>&lt;70%) single nucleotide polymorphisms (SNPs) with genome-wide (GW) significance (<italic>p</italic>&lt;<italic>p<sub>GW</sub></italic>=5&#215;10<sup>-8</sup>). They include two novel and 16 previously reported SNPs attained GW significance in univariate meta-analysis of individual phenotypes, and 115 novel and nine previously reported SNPs attained GW significance in pleiotropic meta-analysis. We show that pleiotropic associations for most novel SNPs, 93.9% (108 of 115 SNPs), and for all replicated SNPs were strongly affected by the natural-selection&#8211;free genetic heterogeneity in a rarely recognized form of antagonistic heterogeneity, implying antagonistic directions of genetic effects for directly correlated phenotypes.</p></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Study overview</title><p>We performed two-stage univariate and pleiotropic meta-analyses of genetic predisposition to 20 weakly-to-modestly correlated age-related phenotypes (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). The data were drawn from five longitudinal studies for 33,431 men and women combined, who identified themselves as of Caucasian ancestry. In stage 1, we first performed simplified univariate GWAS of each phenotype in each cohort separately using <italic>plink</italic> software [<xref rid="r21" ref-type="bibr">21</xref>]. Then, these results were prioritized and top 1,000 promising SNPs were selected for more comprehensive analysis leveraging information on repeated measurements for quantitative markers and timing of the risk outcomes (<xref ref-type="table" rid="t1">Tables 1</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). In stage 2, we performed univariate meta-analysis to combine statistics for these 1,000 selected SNPs across cohorts and pleiotropic meta-analysis to combine such statistics across phenotypes. These analyses addressed the natural-selection&#8211;free genetic heterogeneity in genetic predisposition to age-related phenotypes (see the Introduction) by performing five meta-tests (<xref ref-type="fig" rid="f1">Fig. 1</xref>) (details in Methods).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Basic characteristics of cohorts included in the analyses.</title></caption><table-wrap-foot><p><bold>Cohort</bold>: Atherosclerosis Risk in Communities Study (ARIC); Cardiovascular Health Study (CHS); Framingham Heart Study (FHS), the Multi-Ethnic Study of Atherosclerosis (MESA), and Health and Retirement Study (HRS).</p><p><bold>Age</bold> is given at baseline; standard deviation (SD).</p><p>*Number of visits in the FHS original cohort, offspring and 3<sup>rd</sup> generation cohort are 28, 8, and 2, respectively.</p><p><bold>Quantitative markers</bold>: blood glucose (BG); body mass index (BMI); C-reactive protein (CRP); creatinine; diastolic blood pressure (DBP); forced vital capacity (FVC); heart rate (HR); hematocrit (HC); high-density lipoprotein cholesterol (HDL-C); systolic blood pressure (SBP); total cholesterol (TC); and triglycerides (TG).</p><p><bold>Risk outcomes</bold>: Alzheimer&#8217;s disease and related dementias (AD), atrial fibrillation (AF); cancer; coronary heart disease (CHD); diabetes mellitus (DM); death; heart failure (HF); and stroke.</p><p>Additional details are provided in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>.</p></table-wrap-foot></table-wrap><fig id="f1" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p><bold>Scheme of univariate and pleiotropic meta-analyses in stage 2</bold>. (<bold>A</bold>) Statistics from stage 1 univariate GWAS of 20 phenotypes in five cohorts denoted P<italic>i</italic>C<italic>j</italic>, <inline-formula><mml:math id="m1"><mml:mi mathvariant="normal">i</mml:mi><mml:mo>&#8712;</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mn>1,20</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math></inline-formula> and <inline-formula><mml:math id="m2"><mml:mi mathvariant="normal">j</mml:mi><mml:mo>&#8712;</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mn>1,5</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math></inline-formula>. (<bold>B</bold>) Univariate statistics from the meta-analysis across cohorts using the fixed-effects meta-test (P<italic>i</italic>M) and Fisher test (P<italic>i</italic>Fc). (<bold>C</bold>) Statistics from the pleiotropic meta-analysis across phenotypes in cohort <italic>j</italic> for: (i) omnibus tests with correlation matrix for phenotypes <inline-formula><mml:math id="m3"><mml:msubsup><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> (OpC<italic>j</italic>) and effect statistics <inline-formula><mml:math id="m4"><mml:msubsup><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> (ObC<italic>j</italic>) and (ii) Fisher test (FpC<italic>j</italic>). (<bold>D</bold>) Meta-statistics from Fisher test across cohorts for the results in (<bold>C</bold>) (OpFc, ObFc, and FpFc). (<bold>E</bold>) Meta-statistics across phenotypes for the results in (<bold>B</bold>) from (i) meta-test across cohorts and omnibus test across phenotypes with correlation matrix for phenotypes <inline-formula><mml:math id="m5"><mml:msubsup><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> (MOp), (ii) meta-test across cohorts and omnibus test across phenotypes with correlation matrix for effect statistics <inline-formula><mml:math id="m6"><mml:msubsup><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> (MOb), (iii) meta-test across cohorts and Fisher test across phenotypes (MFp), and (iv) Fisher test across cohorts and Fisher test across phenotypes (FcFp). Pathway 1: meta-analysis combining statistics across cohorts (pathway 1a) and pleiotropic meta-analysis across phenotypes (pathway 1b). Pathway 2: meta-analysis combining statistics across phenotypes (pathway 2a) and cohorts (pathway 2b).</p></caption><graphic xlink:href="aging-10-101407-g001"/></fig></sec><sec><title>Univariate meta-analysis</title><p>Using the Fisher test and a fixed-effect meta-test (<xref ref-type="fig" rid="f1">Fig. 1</xref>, pathway 1a), we identified two novel (see Methods) non-proxy SNPs (defined as LD <italic>r<sup>2</sup></italic>&lt;70%, actual LD for the reported SNPs in the same locus ranged <italic>r<sup>2</sup></italic>=1% to 64%, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>) associated at GW level with HC (rs6745983, <italic>&#946;<sub>meta</sub></italic>=-0.077, <italic>p<sub>meta</sub></italic>=4.2&#215;10<sup>-8</sup>) and BG (rs10885409, <italic>&#946;<sub>meta</sub></italic>=0.672, <italic>p<sub>meta</sub></italic>=1.9&#215;10<sup>-8</sup>) (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 3</xref>). We also replicated (<italic>p</italic>&lt;<italic>p<sub>GW</sub></italic>) 24 associations, primarily with lipids (21 associations), for 16 SNPs in or nearby (within &#177;100 Kb flanking region for the index SNP) 11 protein coding genes (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 3</xref>). Seven associations were replicated in the <italic>LPL</italic>-gene locus. <italic>P-</italic>values were smaller for the meta-test than for the Fisher test (<italic>p<sub>meta</sub></italic>&lt;<italic>p<sub>Fisher</sub></italic>) for all associations except for the associations of rs780094 with BG (<italic>p<sub>meta</sub></italic>=2.7&#215;10<sup>-8</sup> vs. <italic>p<sub>Fisher</sub></italic> =2.4&#215;10<sup>-11</sup>) and rs261332 with TC (<italic>p<sub>meta</sub></italic>=5.1&#215;10<sup>-8</sup> vs. <italic>p<sub>Fisher</sub></italic> =2.7&#215;10<sup>-9</sup>). The Fisher test benefited the meta-analysis because it disregarded strong heterogeneity in the effect sizes across cohorts measured by the heterogeneity coefficient <italic>I<sup>2</sup></italic>, i.e., <italic>I<sup>2</sup></italic>=87.8% for rs780094 and <italic>I<sup>2</sup></italic>=82.2% for rs261332, as supported by significant inverse correlation of the ratio log<sub>10</sub>(<italic>p<sub>meta</sub></italic>)/log<sub>10</sub>(<italic>p<sub>Fisher</sub></italic>) with <italic>I<sup>2</sup></italic>, <italic>r<sub>Pearson</sub></italic>=-0.634, <italic>p</italic>=5.0&#215;10<sup>-4</sup>.</p><p>Significance of the association of rs2155216 with TG in our modest sample of 33,431 individuals (<italic>p<sub>meta</sub></italic>=9.4&#215;10<sup>-14</sup>) was about the same as previously reported (<italic>p<sub>grasp</sub></italic>=1.6&#215;10<sup>-14</sup>) in a sample of 140,059 individuals [<xref rid="r22" ref-type="bibr">22</xref>]. These <italic>p</italic>-values indicate improvement of the efficiency of the analysis that can be quantified by the ratio of the log<sub>10</sub>(<italic>p</italic>-value) to the sample size [<xref rid="r23" ref-type="bibr">23</xref>] yielding 4-fold (=log<sub>10</sub>(9.4&#215;10<sup>-14</sup>)&#215;140,059/log<sub>10</sub>(1.6&#215;10<sup>-14</sup>)/33,431) larger efficiency in our study than in [<xref rid="r22" ref-type="bibr">22</xref>]. This improvement was partly achieved by leveraging longitudinal information on repeated measurements that resulted in smaller standard errors (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2</xref>).</p></sec><sec><title>Pleiotropic meta-analysis</title><p>We used four tests in pathway 1 and three tests in pathway 2 (<xref ref-type="fig" rid="f1">Fig. 1</xref>) to examine pleiotropy in the domains of 12 quantitative markers, 8 diseases and death, and all 20 phenotypes (<xref ref-type="table" rid="t1">Table 1</xref>). Pleiotropic associations were defined as at least one test showing GW significance (see Methods).</p><p>This analysis identified 115 novel pleiotropic SNPs in or nearby (within &#177;100 Kb flanking region for the index SNP) 84 protein coding genes (<xref ref-type="table" rid="t2">Table 2</xref>) and replicated nine SNPs (Supplementary Table 4) with <italic>p<sub>pleio</sub></italic>&lt;<italic>p<sub>GW</sub></italic> by combining associations with multiple phenotypes that individually did not attain GW significance in univariate meta-analysis (<italic>p<sub>uni</sub></italic>&gt;<italic>p<sub>GW</sub></italic>) (<xref ref-type="supplementary-material" rid="SD4">Supplementary Table 5</xref>). SNPs were identified as novel if they did not attain GW significance in our pleiotropic meta-analysis of the results collected in GRASP for the index SNPs or for flanking SNPs, if no results for 20 selected phenotypes (<xref ref-type="fig" rid="f1">Figure 1</xref>) were reported in GRASP for the index SNPs (see Methods). Specifically, of 115 SNPs, 31 were not reported in GRASP for the selected 20 phenotypes. For them, we identified multiple SNPs within &#177;1Mb flanking region in GRASP. For the flanking SNPs, which were in the strongest LD to the index SNPs, no GW significant pleiotropic associations were identified (<xref ref-type="table" rid="t3">Table 3</xref>). Nine flanking SNPs showed GW significant pleiotropic effects, which were independent of the pleiotropic effects for the index SNPs. Of 115 novel SNPs, 29 SNPs attained smaller <italic>p</italic>-value in pathway 1 and the remaining 86 SNPs in pathway 2.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Novel SNPs attained genome-wide significance in pleiotropic meta-analysis.</title></caption><table-wrap-foot><p><sup>1</sup> If an index SNP was not within protein coding gene, the closest gene was assigned. Multiple genes were assigned if they were at about the same distance up- and downstream from the index SNP or if the index SNP was within the region of overlapping genes.</p><p><sup>2</sup> Proxy SNPs with linkage disequilibrium (LD) <italic>r<sup>2</sup></italic>&gt;70% were excluded. LD with <italic>r<sup>2</sup></italic>&gt;1% for SNPs within &#177;1Mb flanking region retained in the table is given in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>.</p><p><sup>*</sup> Protein coding genes within &#177;100 Kb flanking region for the index SNP.</p><p>Chr = chromosome; EA = effect allele; EAF = EA frequency.</p><p><bold>Domain</bold> indicates the pleiotropic domain in which minimal GW significant <italic>p</italic>-values were attained in our pleiotropic meta-analysis examining: 12 quantitative markers (12M), 7 diseases and death (8DD), and all 20 phenotypes (20P) domains. <italic>P</italic>-values are given for all pleiotropic meta-tests for a given domain in a given <bold>Pathway</bold> (<xref ref-type="fig" rid="f1">Fig. 1</xref>).</p><p><bold>Group</bold>: the type of an association defined in the &#8220;Antagonistic genetic heterogeneity in pleiotropic meta-analysis&#8221; section.</p><p><bold><italic>P</italic><sub>GRASP</sub></bold>: <italic>p</italic>-values from the pleiotropic meta-analysis of results for the index SNPs reported in GRASP for phenotypes used in 12M or 20P domain reported in column &#8220;Domain&#8221;. Empty cells: no index SNPs for phenotypes from the corresponding domain (shown in column &#8220;Domain&#8221;) were reported in GRASP.</p><p><bold>N<sub>P</sub></bold> and <bold>N<sub>G</sub></bold> show the number of phenotypes that attained a minimal <italic>p</italic>-value (<italic>p</italic>&lt;0.05) in the meta- or Fisher test in a given phenotypic domain in pathway 1 and Fisher test of GRASP results, respectively.</p><p><bold>P<sub>MOp</sub></bold>, <bold>P<sub>MOb</sub></bold>, <bold>P<sub>MFp</sub></bold>, <bold>P<sub>FcFp</sub></bold>, <bold>P<sub>OpFc</sub></bold>, <bold>P<sub>ObFc</sub></bold>, and <bold>P<sub>FpFc</sub></bold>: <italic>p</italic>-values for meta-tests (subscripts) defined in <xref ref-type="fig" rid="f1">Fig. 1</xref>.</p><p>More details on the associations for these SNPs are given in Supplementary Tables 5 and 6.</p></table-wrap-foot></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><title><italic>P</italic>-values from pleiotropic meta-analysis of GRASP results for SNPs within &#177;1Mb flanking region of the index SNPs not reported in GRASP for 20 selected phenotypes (<xref ref-type="table" rid="t1">Table 1</xref>).</title></caption><table-wrap-foot><p><bold>Chr</bold> = chromosome. <bold>LD</bold>: linkage disequilibrium, <italic>r<sup>2</sup></italic>.</p><p><bold>Strongest LD</bold>: SNPs with the strongest LD reported in GRASP within &#177;1Mb flanking region of the index SNPs.</p><p><bold>Smallest <italic>p</italic>-value</bold>: SNPs from the &#177;1Mb flanking region of the index SNPs attained smallest <italic>p</italic>-values in our pleiotropic meta-analysis of results reported in GRASP.</p><p><bold><italic>P</italic><sub>GRASP</sub></bold>: <italic>p</italic>-values from the pleiotropic meta-analysis of the results for flanking SNPs reported in GRASP.</p></table-wrap-foot></table-wrap><p>All SNPs attained GW significant associations either in the domain of 12 markers (76 of 115 novel SNPs and seven of nine replicated SNPs) or all 20 phenotypes (39 novel and two replicated SNPs). No associations with <italic>p</italic>&lt;<italic>p<sub>GW</sub></italic> were identified in the disease/death domain (<xref ref-type="supplementary-material" rid="SD5">Supplementary Table 6</xref>). The 115 novel and nine replicated SNPs were associated with up to 10 phenotypes at <italic>p</italic>&lt;0.05 (<xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 4</xref>). <xref ref-type="fig" rid="f2">Figure 2</xref> shows 39 novel pleiotropic SNPs attained GW significance in the domain of 20 phenotypes.</p><fig id="f2" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p><bold>Heat map of phenotype-specific associations for selected pleiotropic SNPs</bold>. Data are for 39 novel SNPs with pleiotropic associations in the domains of all 20 phenotypes (20P) from <xref ref-type="table" rid="t2">Table 2</xref>. Numbers in parentheses are SNP IDs in <xref ref-type="table" rid="t2">Table 2</xref>. Phenotypes are defined in <xref ref-type="table" rid="t1">Table 1</xref>. FF, Op, and Ob denote pleiotropic meta-tests either from pathway 1 or 2 based on Fisher test, omnibus test with correlation matrix for phenotypes, and omnibus test with correlation matrix for effect statistics (<xref ref-type="fig" rid="f1">Fig. 1</xref>), respectively. MFp denotes pleiotropic meta-tests from pathway 1 (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Colors code -log<sub>10</sub>(<italic>p</italic>-value) trimmed at GW level -log<sub>10</sub>(5&#215;10<sup>-8</sup>)=7.3 for better resolution.</p></caption><graphic xlink:href="aging-10-101407-g002"/></fig><p>Because <italic>p<sub>pleio</sub></italic>&lt;<italic>p<sub>GW</sub></italic>&lt;<italic>p<sub>uni</sub></italic> for pleiotropic SNPs, this inequality automatically validates pleiotropy for 29 SNPs in pathway 1, as it implies that pleiotropic statistics improved to attain <italic>p<sub>pleio</sub></italic>&lt;<italic>p<sub>GW</sub></italic> by pooling contributions from multiple phenotypes with <italic>p<sub>uni</sub></italic>&gt;<italic>p<sub>GW</sub></italic> (Supplementary Table 5). Likewise, GW significant pleiotropic associations in meta-analysis in pathway 2 were automatically validated for 37 SNPs with <italic>p<sub>pleio</sub></italic>&gt;<italic>p<sub>GW</sub></italic> in each individual cohort (i.e., in pathway 2a) as it implies that pleiotropic statistics improved to attain <italic>p<sub>pleio</sub></italic>&lt;<italic>p<sub>GW</sub></italic> in meta-analysis of individual cohorts. For the remaining 49 SNPs in pathway 2, we observed <italic>p<sub>pleio</sub></italic>&lt;<italic>p<sub>GW</sub></italic> in at least one cohort. For five of these 49 SNPs, pleiotropic associations did not attain Bonferroni adjusted significance level, <italic>p</italic>&lt;0.05/(N<sub>cohorts</sub> &#8211; 1), in at least one additional cohort, whereas they attained that level for the other 44 SNPs (<xref ref-type="supplementary-material" rid="SD6">Supplementary Table 7</xref>).</p></sec><sec><title>Antagonistic genetic heterogeneity in pleiotropic meta-analysis</title><p>Let us assume that an allele is associated with a higher risk of a phenotype <italic>P<sub>1</sub></italic> and that <italic>P<sub>1</sub></italic> is directly correlated with a phenotype <italic>P<sub>2</sub></italic>, e.g. individuals with larger values of <italic>P<sub>1</sub></italic> tend to have larger values of <italic>P<sub>2</sub></italic>. An implicit expectation in medical genetics for partly correlated phenotypes, especially when they are etiologically related, is that the same allele will be also associated with a higher risk of a phenotype <italic>P<sub>2</sub></italic>. In the framework of the undefined role of evolution in establishing molecular mechanisms of age-related phenotypes (see Introduction), this logic may or may not hold because given allele may not be evolutionary selected in favor or against these phenotypes. A simple approach to examine this logic is to compare the results from different tests used in our pleiotropic meta-analysis. Indeed, the Fisher test in pathways 1b and 2a (<xref ref-type="fig" rid="f1">Fig. 1</xref>) combined <italic>p-</italic>values across phenotypes assuming that they were from independent associations whereas the two omnibus tests adjusted the pleiotropic meta-statistics for correlation among phenotypes (<inline-formula><mml:math id="m7"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>-based omnibus test) and the effect statistics (<inline-formula><mml:math id="m8"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>-based omnibus test) (see Methods). Accordingly, the differences in <italic>p-</italic>values from the Fisher and omnibus tests reflect the impacts of heterogeneity and/or correlation in genetic associations. Below, we characterize these impacts. We used an <italic>ad-hoc</italic> cut-off for the difference in <italic>p-</italic>values between these tests of &#8805;2 orders of magnitude to characterize a strong impact.</p><p>Given a common assumption that the Fisher pleiotropic meta-test provides inflated <italic>p</italic>-values for correlated phenotypes, correlation-adjusted estimates in the omnibus tests are expected <italic>p<sub>Omnibus</sub></italic>&gt;<italic>p<sub>Fisher</sub></italic>. Contrary to this expectation, for most novel SNPs, 93.9% (108 of 115 SNPs) and all nine replicated SNPs, we observe an opposite inequality, i.e., <italic>p<sub>Omnibus</sub></italic>&lt;<italic>p<sub>Fisher</sub></italic> by &#8805;2 orders of magnitude (<xref ref-type="table" rid="t2">Table 2</xref> and Supplementary Table 4A). An unconventional set of 108 novel SNPs includes 27 SNPs from HP group in pathway 1, and 54, 5, and 22 SNPs from HP, HB, and HP/HB groups, respectively, in pathway 2 (<xref ref-type="table" rid="t2">Table 2</xref>). The HP group (27+54=81 SNPs) was characterized by attaining GW significance after the <inline-formula><mml:math id="m9"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>-based omnibus tests (i.e., OpFc or MOp, <xref ref-type="fig" rid="f1">Fig. 1</xref>) and substantially larger (&#8805;2 orders of magnitude) <italic>p</italic>-values in the Fisher pleiotropic meta-tests, i.e., <italic>p<sub>MOp</sub></italic>&lt;<italic>p<sub>MFp</sub></italic> for pathway 1 and <italic>p<sub>OpFc</sub></italic>&lt;<italic>p<sub>FpFc</sub></italic> for pathway 2. The HB group (5 SNPs) resembled the HP group except for having <italic>p<sub>ObFc</sub></italic>&lt;<italic>p<sub>FpFc</sub></italic>. The HP/HB group (22 SNPs) was characterized by attaining GW significance after the <inline-formula><mml:math id="m10"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>- and <inline-formula><mml:math id="m11"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>-based omnibus tests (<italic>p<sub>OpFc,</sub> p<sub>ObFc</sub></italic>&lt;<italic>p<sub>FpFc</sub></italic>) and substantially larger (&#8805;2 orders of magnitude) <italic>p</italic>-values in the Fisher pleiotropic meta-tests (<italic>p<sub>FpFc</sub></italic>).</p><p>These results show that majority of novel SNPs with pleiotropic associations, 93.9%, is characterized by a strong impact of unconventional (natural-selection&#8211;free) genetic heterogeneity rather than commonly expected correlation. This form of the natural-selection&#8211;free genetic heterogeneity, called antagonistic heterogeneity, is schematically illustrated in <xref ref-type="fig" rid="f3">Fig. 3</xref> for two partly correlated phenotypes P1 and P2. This heterogeneity results in orthogonal directions of the bivariate vector of genetic effects <bold>&#946;<sub>1</sub></bold> and <bold>&#946;<sub>2</sub></bold> for phenotypes P1 and P2 and the vector of the correlation of these phenotypes and, accordingly, in opposite directions of vectors <bold>&#946;<sub>2</sub></bold> and <bold>P<sub>2</sub></bold>. As seen from <xref ref-type="fig" rid="f3">Fig. 3</xref>, the antagonistic heterogeneity implies antagonistic directions of genetic effects for directly correlated phenotypes (see Methods).</p><fig id="f3" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label><caption><p><bold>Schematic illustration of antagonistic genetic heterogeneity in the associations with two partly correlated age-related phenotypes P1 and P2</bold>. Small dots represent a sample of carriers of an effect allele A (red color) and those who do not carry this allele (no A; green color). Ellipse shows correlation of P1 and P2 in this sample (<italic>r</italic>=0.6). Red color denotes vector of correlation of P1 and P2 (thick diagonal vector) and its projections on phenotypes, i.e. <bold>P<sub>1</sub></bold> (horizontal) and <bold>P<sub>2</sub></bold> (vertical). Black vectors <bold>&#946;<sub>1</sub></bold> and <bold>&#946;<sub>2</sub></bold> denote the effects in the associations of allele A with P1 and P2. Sum of <bold>&#946;<sub>1</sub></bold> and <bold>&#946;<sub>2</sub></bold> represents bivariate vector (thick line) of the effects.</p></caption><graphic xlink:href="aging-10-101407-g003"/></fig><p>Pathway 2 provides a natural opportunity to validate the antagonistic heterogeneity in different cohorts. Our analysis shows that this heterogeneity, characterized by <italic>p<sub>OpFc</sub></italic>, <italic>p<sub>ObFc</sub></italic>&lt;<italic>p<sub>FpFc</sub></italic> with a difference of &#8805;0.2 orders of magnitude for associations with suggestive significance (<italic>p<sub>OpFc</sub></italic>, <italic>p<sub>ObFc</sub></italic> &lt;0.1 or <italic>p<sub>FpFc</sub></italic>&lt;0.1), was replicated for 77 of 81 novel pleiotropic SNPs in two or more cohorts (<xref ref-type="supplementary-material" rid="SD7">Supplementary Table 8</xref>).</p><p>Lastly, the M group (7 SNPs) included 2 SNPs from pathway 1 and 5 SNPs from pathway 2. It was characterized by attaining GW significance in several tests and/or minor (&lt;2 orders of magnitude) differences between <italic>p</italic>-values in OpFc and FpFc tests (pathway 2) and MOp and MFp (pathway 1).</p></sec><sec><title>Bioinformatics analysis</title><p>We performed biological pathway (IPA, <ext-link ext-link-type="uri" xlink:href="http://www.qiagenbioinformatics.com">www.qiagenbioinformatics.com</ext-link>) and gene ontology (GO) biological processes (BPs) (DAVID [<xref rid="r24" ref-type="bibr">24</xref>]) enrichment analysis for 96 protein coding genes mapped from 108 pleiotropic SNPs (<xref ref-type="table" rid="t2">Table 2</xref>). We excluded genes for five non-validated SNPs (<xref ref-type="table" rid="t2">Table 2</xref>, ID 1, 24, 25, 49, and 95) and for two SNPs (<xref ref-type="table" rid="t2">Table 2</xref>, ID 53, 55) from the Major Histocompatibility Complex (MHC). The GO analysis (by DAVID 6.8 GO category &#8220;GO_direct&#8221;) identified 10 BPs with enrichment for genes at <italic>p</italic>&lt;0.05 (Fisher&#8217;s exact test) (<xref ref-type="supplementary-material" rid="SD8">Supplementary Table 9</xref>). Two specific terms, <italic>adenylate cyclase-activating G-protein coupled receptor signaling pathway</italic> and <italic>activation of adenylate cyclase activity</italic>, were enriched at <italic>p</italic>&lt;10<sup>-4</sup> and <italic>p</italic>&lt;10<sup>-3</sup>, respectively. The IPA analysis identified 18 pathways (<xref ref-type="supplementary-material" rid="SD9">Supplementary Table 10</xref>) enriched for genes at <italic>p</italic>&lt;0.05 (Fisher&#8217;s exact test). The strongest enrichment was observed for <italic>G-protein coupled receptor signaling</italic> (<italic>p</italic>&lt;10<sup>-4</sup>), <italic>GPCR-mediated integration of enteroendocrine signaling exemplified by an L cell</italic> and <italic>cAMP-mediated signaling</italic> (<italic>p</italic>&lt;10<sup>-3</sup>) (<xref ref-type="fig" rid="f4">Figure 4</xref>) that is consistent with enrichment of GO BPs.</p><fig id="f4" fig-type="figure" orientation="portrait" position="float"><label>Figure 4</label><caption><p><bold>Enrichment of pathways in the Ingenuity Pathway Analysis (IPA) bioinformatics tool</bold>. Blue bars (upper x-axis) show &#8211;log<sub>10</sub>(<italic>p</italic>-value) for the top five IPA pathways. Proportion of genes from the identified sets to those in the IPA pathways (orange symbols and line) is shown on the lower <italic>x</italic>-axis. Numerical estimates are given <xref ref-type="supplementary-material" rid="SD9">Supplementary Table 10</xref>.</p></caption><graphic xlink:href="aging-10-101407-g004"/></fig></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Our univariate and pleiotropic meta-analyses of 20 age-related phenotypes dealing with the natural-selection&#8211;free genetic heterogeneity identified large number of non-proxy SNPs, 142 SNPs, with GW significance in a relatively modest sample of 33,431 individuals of Caucasian ancestry from five longitudinal studies (<xref ref-type="fig" rid="f5">Figure 5</xref>). Only 18 SNPs (12.7%) were identified in the univariate meta-analysis with most SNPs, 88.9% (16 of 18 SNPs), replicating previously reported associations, primarily with lipids. Two novel SNPs were associated with HC (rs6745983 in <italic>TMEM163</italic> gene) and BG (rs10885409 in <italic>TCF7L2</italic> gene). Two of 16 replicated SNPs, rs780094 (<italic>GCKR</italic> gene) and rs261332 (<italic>LIPC/LIPC-AS1</italic> genes) associated with BG and TC, respectively, showed evidences for inter-cohort heterogeneity in the effect sizes. Accordingly, smaller <italic>p</italic>-values were attained by addressing this heterogeneity. The association of rs2155216 (<italic>BUD13-ZPR1/APOA5</italic> gene locus) with TG was replicated with substantially higher (4-fold) efficiency in our analysis than in previous study [<xref rid="r22" ref-type="bibr">22</xref>] that was achieved, in part, by leveraging information on repeated measurements from longitudinal follow up.</p><fig id="f5" fig-type="figure" orientation="portrait" position="float"><label>Figure 5</label><caption><p><bold>Summary of SNPs identified in the univariate and pleiotropic meta-analyses</bold>. Green and blue colors denote novel and replicated SNPs, respectively.</p></caption><graphic xlink:href="aging-10-101407-g005"/></fig><p>Most SNPs, 87.3% (124 of 142 SNPs), were identified in our pleiotropic meta-analyses and most of them, 92.7% (115 of 124 SNPs), were novel (<xref ref-type="fig" rid="f5">Figure 5</xref>). Novel pleiotropic SNPs attained GW significance by combining associations with multiple phenotypes, which individually did not attain GW significance in univariate meta-analysis (<xref ref-type="fig" rid="f2">Figure 2</xref>). Therefore, pleiotropic meta-analysis has power to identify SNPs leveraging signals, which are often considered as noise in univariate GWAS. Most importantly, our analysis showed that the associations for most novel pleiotropic SNPs, 93.9% or 108 of 115 SNPs (and all 9 replicated SNPs) were strongly affected by the natural-selection&#8211;free genetic heterogeneity in a rarely recognized form of antagonistic heterogeneity, implying antagonistic directions of genetic effects for directly correlated phenotypes. This heterogeneity has not been addressed in the currently prevailing GWAS.</p><p>Thus, our analysis provides compelling evidences that the traditional sample-size-centered GWAS approach is well adapted to handle homogeneous univariate associations (one SNP &#8211; one phenotype) within Mendelian framework whereas most associations with age-related phenotypes are more complex and well beyond that framework. This complexity substantially decreases the efficiency of the analysis of such phenotypes within the current GWAS framework. This conclusion leads to three major implications.</p><p>First, discovery of a large number of common genetic variants associated with different phenotypes in GWAS [<xref rid="r25" ref-type="bibr">25</xref>], raised concern known as a &#8220;missing heritability problem&#8221; [<xref rid="r26" ref-type="bibr">26</xref>]. The problem is that the estimated variance attributed to GWAS-identified common SNPs is only a fraction of the expected genetic variance from the estimates of heritability of a phenotype. This problem even leads to questioning whether genetics could be helpful for improving health care [<xref rid="r27" ref-type="bibr">27</xref>]. Our results show that in large part missing heritability problem for age-related phenotypes can be due to missing associations with complex genetic predisposition to these phenotypes.</p><p>Second, the traditional GWAS approach is built on the concept of a &#8220;true&#8221; or causal genetic effect (see the Introduction) whereas biologically plausible concept for age-related phenotypes is that based on the undefined role of evolution in establishing their molecular mechanisms. The letter implies that the same genetic variant can predispose differently to the same phenotype in different population groups, even of the same ancestry, e.g., throughout the life course and/or across generations. This concept particularly implies that &#8220;small&#8221; genetic effects (often expected in GWAS of age-related phenotypes) can be due to a complex superposition of large effects rather than small penetrance. Then, just relaying on large samples in GWAS of age-related phenotypes without dissecting the natural-selection&#8211;free genetic heterogeneity is inefficient because increasing the sample size will also increase heterogeneity [<xref rid="r28" ref-type="bibr">28</xref>]. The current study supports this concept by highlighting strong impact of antagonistic heterogeneity, which is counter-intuitive in medical genetics but natural within the evolutionary framework. The antagonistic heterogeneity is also supported by the analyses of alleles from well-known apolipoprotein B and E genes [<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>].</p><p>Third, all pleiotropic SNPs attained GW significance in the two largest domains of 12 quantitative markers and all 20 phenotypes. These findings support the hypothesis that pleiotropic predisposition to age-related phenotypes can be driven by fundamental mechanisms associated with aging [<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r29" ref-type="bibr">29</xref>]. This attractive hypothesis in gerontology conceptualized as geroscience [<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r30" ref-type="bibr">30</xref>] is based on observations that aging-related processes [<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r32" ref-type="bibr">32</xref>] are among the most important risk factors for geriatric diseases of distinct etiologies. The dominant role of antagonistic heterogeneity in pleiotropic associations cautions against simplistic approaches in studies of pleiotropic effects on age-related phenotypes and emphasizes the importance of personalized medicine which can potentially handle complexity of risk profiles on an individual basis [<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref>]. Dissecting the role of antagonistic heterogeneity is particularly important as this provides a genetic basis for strategies focusing on anti-side-effect treatments in medical care.</p><p>Finally, our bioinformatics analysis of genes for pleiotropic SNPs identified three interlinked pathways, G<italic>-protein coupled receptor signaling, GPCR-mediated integration of enteroendocrine signaling exemplified by an L cell</italic>, and <italic>cAMP-mediated signaling</italic>. G-protein coupled receptors (GPCRs), members of the largest family of membrane proteins, are activated by a wide variety of external signals (e.g., light, odorants, hormones, neurotransmitters, pharmacologic agents, etc.) and modulate the activity of signaling pathways involved in most physiological processes. In particular, GPCRs partly mediate secretion of enteroendocrine peptide hormones glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) by L-cells, relevant to food intake and blood glucose homeostasis [<xref rid="r35" ref-type="bibr">35</xref>,<xref rid="r36" ref-type="bibr">36</xref>]. GPCRs play a causative role in many human diseases and are the important drug targets [<xref rid="r37" ref-type="bibr">37</xref>,<xref rid="r38" ref-type="bibr">38</xref>]. Adenylyl cyclase, a membrane-associated enzyme, when activated by G proteins, catalyzes synthesis of important second messenger cyclic adenosine monophosphate (cAMP). cAMP is involved in diverse biological processes (e.g., glycogen metabolism, hormone regulation, gene expression, sensory signal transduction). The cAMP levels also partly mediate secretion of enteroendocrine peptide hormones linked to feeding/metabolic control [<xref rid="r35" ref-type="bibr">35</xref>] and are associated with immune function [<xref rid="r39" ref-type="bibr">39</xref>]. Top GO BPs (<italic>adenylate cyclase-activating G-protein coupled receptor signaling pathway</italic> and <italic>activation of adenylate cyclase activity</italic>) support an enrichment of BPs related to GPCRs function and cAMP synthesis. Thus, these results suggest an important role of G protein-dependent signaling and adenylyl cyclase activity necessary for the proper biological response of cells to hormones and other extracellular signals in pleiotropic effect on age-related phenotypes.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study cohorts</title><p>Data were drawn from the Atherosclerosis Risk in Communities (ARIC) study [<xref rid="r40" ref-type="bibr">40</xref>,<xref rid="r41" ref-type="bibr">41</xref>], the Cardiovascular Health Study (CHS) [<xref rid="r42" ref-type="bibr">42</xref>], the Multi-Ethnic Study of Atherosclerosis (MESA) [<xref rid="r43" ref-type="bibr">43</xref>], the Framingham Heart Study (FHS) [<xref rid="r44" ref-type="bibr">44</xref>-<xref rid="r46" ref-type="bibr">46</xref>], and the Health and Retirement Study (HRS) [<xref rid="r47" ref-type="bibr">47</xref>] for individuals who identified themselves as of Caucasian ancestry.</p></sec><sec><title>Phenotypes</title><p>The analyses focused on 20 phenotypes (12 quantitative markers, 7 diseases, and death) listed in <xref ref-type="table" rid="t1">Table 1</xref>. Given longitudinal design of the studied cohorts, the analyses leveraged repeated measurements of quantitative markers during follow up and timing information on onsets of diseases or death (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). These not strongly correlated phenotypes (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>) were available in majority of the selected cohorts. All studies except HRS collected information on diseases and death in population samples during follow-up. The HRS assessed information on date of death from the National Death Index Cause of Death file. Age at onset of diseases in HRS was assessed from the linked Medicare service use files, which include enrollment information and the diagnoses made (International Classification of Disease-revision 9, Clinical Modification) during episodes of care paid for by the Medicare system.</p></sec><sec><title>Genotyping</title><p>SNPs were available from Affymetrix 1M chip in ARIC and MESA, Illumina CVDSNP55v1_A chip (~50K SNPs) in FHS and CHS cohorts, Illumina HumanCNV370v1 chip (370K SNPs) in CHS, Affymetrix 500K in FHS, and Illumina HumanOmni 2.5 Quad chip (~2.5M SNPs) in HRS. SNPs were included in the analyses after quality control in each study (call rate&gt;95%, Hardy-Weinberg disequilibrium <italic>p</italic>&lt;10<sup>-6</sup>, minor allele frequency [MAF] &gt;2%). In case of marginally smaller MAF for prioritized SNPs in a specific cohort compared to the MAF cut off, these SNPs were used regardless of the MAF cut off. To facilitate cross-platform comparisons, we selected directly genotyped (index) SNPs using all available arrays for each study. Non-genotyped SNPs were imputed (IMPUTE2 [<xref rid="r48" ref-type="bibr">48</xref>],) according to the 1000 Genomes Project Phase I integrated variant set release (SHAPEIT2) in the NCBI build 37 (hg19) coordinate. Only SNPs with high imputation quality (info&gt;0.8) were retained for the analyses.</p></sec><sec><title>Mapping to genes</title><p>SNPs were mapped to genes using variant effect predictor from Ensembl and NCBI SNP database (assembly GRCh38.p7). If an index SNP was not within protein coding gene, the closest gene(s) within &#177;100 Kb flanking region was (were) assigned. Multiple genes were selected if they were at about the same distance up- and downstream from the index SNP or the index SNP was within the region of overlapping genes.</p></sec><sec><title>Selecting SNPs in univariate GWAS in stage 1</title><p>GWAS was performed for each phenotype in each cohort separately using <italic>plink</italic> software [<xref rid="r21" ref-type="bibr">21</xref>]. In this analysis, we used quantitative markers measured at baseline, and diseases and death as binary outcomes. An additive genetic model with minor allele as an effect allele was adopted in all analyses throughout this article. We computed pleiotropic <italic>p</italic>-value by combining <italic>p</italic>-values for individual markers and binary outcomes for SNPs attained nominal significance only (<italic>p</italic>&lt;0.05) using Fisher&#8217;s test [<xref rid="r49" ref-type="bibr">49</xref>]. This computationally efficient but overly-simplified approach was used for prioritizing of promising SNPs. Because this procedure provides inflated <italic>p</italic>-values, we selected top 1,000 SNPs (with smallest <italic>p</italic>-values) for all downstream analyses, rather than selecting SNPs based on specific cut off for pleiotropic <italic>p</italic>-values.</p></sec><sec><title>Leveraging longitudinal information in stage 1 analysis</title><p>The analysis of the selected 1,000 SNPs were enhanced by leveraging longitudinal information. For quantitative markers, we used all measurements available during follow up of the same individuals. Information on longitudinal measurements has multiple advantages including potential gain in statistical power in the analyses [<xref rid="r50" ref-type="bibr">50</xref>]. To correct for repeated-measurements (all cohorts) and familial (FHS) correlations in the analyses of quantitative markers, we mostly used the linear mixed effects model (<italic>lme4</italic> package in R [<xref rid="r51" ref-type="bibr">51</xref>]). Measurements of BG, BMI, HDL-C, HR, TC, and TG were natural-log-transformed to offset potential bias due to skewness of their frequency distributions. They were multiplied by 100 for better resolution. Measurements of creatinine, DBP, FVC, HC and SBP were used in their natural scale as no significant skewness was observed. Given gamma-like frequency distributions of CRP, a generalized linear mixed model (glmmPQL package in R) with a gamma function and log-link was used. We evaluated the associations for SNPs given the measurements of quantitative markers for individuals of a given age at each examination with available measurements.</p><p>Longitudinal information on time to events was implemented in the Cox proportional hazards mixed effects model (<italic>coxme</italic> package in R). This model addressed familial relatedness. In the FHS, we used both prospective and retrospective onsets. The use of retrospective onsets in a failure-type model is justified by Prentice, Breslow [<xref rid="r52" ref-type="bibr">52</xref>]. These analyses provide estimates of the effects in a given population. Time variable in these analyses was the age at onset of an event or at right censoring.</p><p>The models were adjusted for: (all studies) age and sex; (ARIC, CHS, and MESA) field center; (HRS) HRS cohorts, and (FHS) whether the DNA samples had been subject to whole-genome amplification [<xref rid="r53" ref-type="bibr">53</xref>]. No adjustment for principal components was performed as argued in Ref [<xref rid="r54" ref-type="bibr">54</xref>].</p></sec><sec><title>Meta-analyses in stage 2</title><p>After stage 1, for each SNP we have a table with the association statistics for up to 20 phenotypes in 5 cohorts. These statistics were combined along two possible pathways: (i) first across studies and then across phenotypes and (ii) first across phenotypes and then across studies. To deal with the natural-selection&#8211;free heterogeneity in genetic predisposition to age-related phenotypes (see below), we used four tests in pathway 1 and three tests in pathway 2 (<xref ref-type="fig" rid="f1">Fig. 1</xref>).</p><p>In pathway 1, univariate (phenotype-specific) meta-analysis combining the stage 1 statistics for the selected SNPs across cohorts (pathway 1a) was performed using the Fisher test and the traditional GWAS fixed-effects meta-test. Pleiotropic meta-analysis (pathway 1b) was performed by combining the univariate meta-statistics for the same SNPs across phenotypes. In pathway 1b, we used the Fisher test and two omnibus tests. The latter were designed to address correlations between the effect statistics and phenotypes. In pathway 2, we performed first pleiotropic meta-analysis by combining the stage 1 univariate statistics across phenotypes in each cohort separately (pathway 2a) using the Fisher test and the two omnibus tests as in pathway 1b. Then, we combined these pleiotropic meta-statistics across cohorts using the Fisher test (pathway 2b) (details on all tests are below).</p></sec><sec><title>Fixed-effects meta-test</title><p>We adopted a conventional GWAS meta-test using a fixed effects model with inverse-variance weighting (METAL software [<xref rid="r55" ref-type="bibr">55</xref>]). This test combines the estimated effect sizes across cohorts for each phenotype. Combining effect sizes is feasible because each phenotype was harmonized to be on the same scale and unit across cohorts. This meta-test could account for the directions of effects in different cohorts, and is more powerful than those tests that combines <italic>p</italic>-values or Z-scores [<xref rid="r56" ref-type="bibr">56</xref>]. In pathway 1a, the weighted average of the effect sizes was calculated as <inline-formula><mml:math id="m12"><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> with variance 1/<inline-formula><mml:math id="m13"><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula>, where <inline-formula><mml:math id="m14"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the inverse variance of effect size <inline-formula><mml:math id="m15"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mi>&#160;</mml:mi></mml:math></inline-formula>in the cohort <inline-formula><mml:math id="m16"><mml:mi>j</mml:mi><mml:mo>&#8712;</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mn>1,5</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math></inline-formula> for a given phenotype and SNP. Wald test was then used to obtain <italic>p</italic>-value.</p></sec><sec><title>Fisher&#8217;s test</title><p>The Fisher method [<xref rid="r49" ref-type="bibr">49</xref>] combines <italic>p-</italic>values assuming that they are from independent tests. In pathway 1a, this test combines <italic>p</italic>-values across cohorts. It has power to reject the &#8220;null&#8221; hypothesis of no pooled effect regardless of the effect sizes and directions in the cohort-specific estimates. Accordingly, the Fisher test can indicate heterogeneity in genetic associations by providing smaller <italic>p-</italic>value than that from the fixed-effects meta-test. In pathways 1b and 2a, the Fisher test combines <italic>p</italic>-values across phenotypes. This test is often used for pleiotropic meta-analysis of modestly correlated phenotypes [<xref rid="r57" ref-type="bibr">57</xref>]. Because the Fisher method combines <italic>p</italic>-values from multiple tests, it addresses the problem of multiple testing by increasing the number of degrees of freedom.</p></sec><sec><title>Omnibus tests</title><p>The statistics from tests of the same SNPs with different phenotypes may or may not be independent. It is then argued that tests penalizing for correlation of such statistics should be used to deflate the Fisher test estimates. A commonly adopted test in this case is an omnibus test [<xref rid="r58" ref-type="bibr">58</xref>-<xref rid="r60" ref-type="bibr">60</xref>].</p><p>For a certain SNP we have an estimated effect size <inline-formula><mml:math id="m17"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and its standard error <inline-formula><mml:math id="m18"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#963;</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for the phenotype <inline-formula><mml:math id="m19"><mml:mi>i</mml:mi><mml:mo>&#8712;</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math></inline-formula> in the cohort <inline-formula><mml:math id="m20"><mml:mi>j</mml:mi><mml:mo>&#8712;</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mn>1,5</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math></inline-formula>, where <inline-formula><mml:math id="m21"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the number of phenotypes in study <inline-formula><mml:math id="m22"><mml:mi>j</mml:mi></mml:math></inline-formula>. The omnibus test statistic is constructed as <inline-formula><mml:math id="m23"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mi>'</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> where <inline-formula><mml:math id="m24"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">&#946;</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">&#963;</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is a <italic>z</italic>-score vector of associations of SNPs with phenotypes and <inline-formula><mml:math id="m25"><mml:msub><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the correlation matrix of the <italic>z</italic>-scores to be estimated [<xref rid="r58" ref-type="bibr">58</xref>,<xref rid="r59" ref-type="bibr">59</xref>]. Accordingly, this test takes into account the correlation of the effect statistics for different phenotypes. Under the null hypothesis (<inline-formula><mml:math id="m26"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula>), the test statistic follows a chi-squared distribution with <inline-formula><mml:math id="m27"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> degrees of freedom</p><disp-formula id="e"><mml:math id="m28"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mi mathvariant="normal">'</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#967;</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mi mathvariant="normal">&#160;</mml:mi><mml:mo>,</mml:mo></mml:math></disp-formula><p>from which we obtained a combined <italic>p-</italic>value <inline-formula><mml:math id="m29"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in the study <inline-formula><mml:math id="m30"><mml:mi>j</mml:mi></mml:math></inline-formula>. Accordingly, this statistic addresses the problem of multiple testing by increasing the number of degrees of freedom.</p><p>Correlation matrices <inline-formula><mml:math id="m31"><mml:mi mathvariant="bold">&#931;</mml:mi></mml:math></inline-formula> were estimated based on the effect statistics of simulated SNPs in association models with phenotypes (denoted <inline-formula><mml:math id="m32"><mml:mi mathvariant="bold">&#931;</mml:mi><mml:mo>&#8801;</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>). We randomly permuted the dosage data for alleles of a given SNP for 250 times, used each permuted SNP in association models with each of <italic>K</italic> phenotypes, and estimated <inline-formula><mml:math id="m33"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> based on the 250 effect sizes of permuted SNPs with <italic>K</italic> phenotypes. Likewise, <inline-formula><mml:math id="m34"><mml:mi mathvariant="bold">&#931;</mml:mi></mml:math></inline-formula> can be also constructed by evaluating the correlations between phenotypes [<xref rid="r61" ref-type="bibr">61</xref>] (denoted <inline-formula><mml:math id="m35"><mml:mi mathvariant="bold">&#931;</mml:mi><mml:mo>&#8801;</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula><bold>)</bold>. The correlation matrices, <inline-formula><mml:math id="m36"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> and <inline-formula><mml:math id="m37"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula><bold>,</bold> were constructed for pathways 1 and 2 (<xref ref-type="fig" rid="f1">Fig. 1</xref>) separately. Cohort-specific matrices <inline-formula><mml:math id="m38"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for pathway 2 were constructed by evaluating correlations of the effect statistics in each cohort. For pathway 1, matrix <inline-formula><mml:math id="m39"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was constructed by evaluating correlations of the effect statistics from a fixed effect meta-test of all cohorts for each permutation. The phenotype-based cohort-specific matrices for pathway 2, <inline-formula><mml:math id="m40"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula>, were evaluated using phenotype measurements in each cohort separately and matrix for pathway 1, <inline-formula><mml:math id="m41"><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula>, was evaluated using phenotype measurements in the combined data from all cohorts. All correlation matrices were constructed using averaged values for quantitative traits measured longitudinally at different visits.</p></sec><sec><title>Correlation and genetic heterogeneity</title><p>Omnibus tests are commonly used to penalize correlation between the effect statistics or phenotypes in pleiotropic meta-analysis. This can be explicitly illustrated by the test statistics <inline-formula><mml:math id="m42"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mi>'</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in two-dimensional case,</p><disp-formula id="e1"><mml:math id="m43"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mi mathvariant="normal">'</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>22</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>/</mml:mo><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="bold">&#931;</mml:mi><mml:mo>)</mml:mo><mml:mi mathvariant="normal">&#160;</mml:mi></mml:math>.<label>(1)</label></disp-formula><p>Either the <inline-formula><mml:math id="m44"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">B</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> or <inline-formula><mml:math id="m45"><mml:msup><mml:mrow><mml:mi mathvariant="bold">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula>-based omnibus test (see above) penalize pleiotropic meta-statistics, if <inline-formula><mml:math id="m46"><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula>.</p><p>The undefined role of evolution in establishing molecular mechanisms of age-related phenotypes is the source of genetic heterogeneity, which is driven by the lack, rather than the presence, of the evolutionary pressure in favor or against these phenotypes. The natural-selection&#8211;free genetic heterogeneity suggests that mechanisms driving associations of genes with age-related phenotypes and correlation between these phenotypes are, generally, of different origins. In case of antagonistic genetic heterogeneity (see &#8220;Antagonistic genetic heterogeneity in pleiotropic meta-analysis&#8221; section), omnibus test provides smaller <italic>p-</italic>values compared to the Fisher test as can be seen from (1) because <inline-formula><mml:math id="m47"><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi mathvariant="normal">&#931;</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula> in this case.</p></sec><sec><title>Significance and novelty</title><p>The fixed-effect, Fisher, and two omnibus meta-tests used in our analyses have power to identify associations, adjusted and unadjusted for correlation and heterogeneity in genetic predisposition to age-related phenotypes (see above). Fisher and two omnibus tests used in pleiotropic meta-analysis address the problem of multiple testing by increasing the number of degrees of freedom. Accordingly, GW level (<italic>p</italic>=5&#215;10<sup>-8</sup>) attained in either of these tests was used as a cut off for the significance for a given SNP. The difference between <italic>p</italic>-values from these tests for a given SNP was used to characterize the impact of correlation and heterogeneity on the association.</p><p>SNPs were considered as novel if they attained GW significance in: (i) our univariate meta-analysis but were not reported in GRASP catalog [<xref rid="r62" ref-type="bibr">62</xref>] at <italic>p</italic>&#8804;5&#215;10<sup>-8</sup> or (ii) our pleiotropic meta-analysis but not in our pleiotropic analysis of the results collected in GRASP. For univariate meta-analysis, we used evidences for the same (index) SNP in our study and GRASP. For pleiotropic meta-analysis, we selected associations from GRASP for the index SNPs with 20 phenotypes used in our analysis (<xref ref-type="table" rid="t1">Table 1</xref>). If an index SNP was not available in GRASP for the selected phenotypes, we selected SNPs within &#177;1Mb flanking region. Then we performed pleiotropic meta-analysis by applying the Fisher method to these GRASP results to present evidence for pleiotropy in prior studies. We used the Fisher statistics <italic>p<sub>grasp</sub></italic> because the effect sizes were not reported in GRASP. We used a flat <italic>p</italic>-value, <italic>p</italic>=0.4, to penalize the Fisher statistics for phenotypes with <italic>p-</italic>values not reported in GRASP. For flanking SNPs, we reported associations for SNPs having: (i) the strongest LD with the index SNP and (ii) the smallest <italic>p<sub>grasp</sub></italic> for SNPs within &#177;1Mb flanking region.</p></sec><sec><title>Heterogeneity coefficient</title><p>We used METAL software [<xref rid="r55" ref-type="bibr">55</xref>] to evaluate the heterogeneity coefficient I<sup>2</sup>. The I<sup>2</sup> can be interpreted as the percentage of the total variability in a set of effect sizes due to between-sample variability.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary File</label><media mimetype="application" mime-subtype="pdf" xlink:href="aging-10-101407-s001.pdf" orientation="portrait" xlink:type="simple" id="d35e7736" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Table 3</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s002.xlsx" orientation="portrait" xlink:type="simple" id="d35e7740" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplementary Table 4</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s003.xlsx" orientation="portrait" xlink:type="simple" id="d35e7744" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Supplementary Table 5</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s004.xlsx" orientation="portrait" xlink:type="simple" id="d35e7748" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplementary Table 6</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s005.xlsx" orientation="portrait" xlink:type="simple" id="d35e7752" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><label>Supplementary Table 7</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s006.xlsx" orientation="portrait" xlink:type="simple" id="d35e7756" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><label>Supplementary Table 8</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s007.xlsx" orientation="portrait" xlink:type="simple" id="d35e7760" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD8"><label>Supplementary Table 9</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s008.xlsx" orientation="portrait" xlink:type="simple" id="d35e7764" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD9"><label>Supplementary Table 10</label><media mimetype="application" mime-subtype="xlsx" xlink:href="aging-10-101407-s009.xlsx" orientation="portrait" xlink:type="simple" id="d35e7768" position="anchor"/></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>The Atherosclerosis Risk in Communities Study (ARIC) is carried out as a collaborative study supported by the NHLBI contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. Funding for GENEVA was provided by the National Human Genome Research Institute grant U01HG004402 (E. Boerwinkle).</p><p>The Cardiovascular Health Study (CHS) was supported by contracts HHSN268201200036C, HHSN268200800007C, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and N01-HC-85239; grant numbers U01 HL080295 and U01 HL130014 from the National Heart, Lung, and Blood Institute (NHLBI), and R01 AG-023629 from the National Institute on Aging, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at <ext-link ext-link-type="uri" xlink:href="https://chs-nhlbi.org/pi">https://chs-nhlbi.org/pi</ext-link>. This manuscript was not prepared in collaboration with CHS investigators and does not necessarily reflect the opinions or views of CHS, or the NHLBI. Additional support for infrastructure was provided by HL105756 and additional genotyping among the African-American cohort was supported in part by HL085251. DNA handling and genotyping at Cedars-Sinai Medical Center was supported in part by National Center for Research Resources grant UL1RR033176, now at the National Center for Advancing Translational Technologies CTSI grant UL1TR000124; in addition to the National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center.</p><p>The Framingham Heart Study (FHS) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195 and HHSN268201500001I). This manuscript was not prepared in collaboration with investigators of the FHS and does not necessarily reflect the opinions or views of the FHS, Boston University, or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. Funding for CARe genotyping was provided by NHLBI Contract N01-HC-65226. Funding support for the Framingham Dementia dataset was provided by NIH/NIA grant R01 AG08122. Funding support for the Framingham C-reactive Protein dataset was provided by NIH grants R01 HL064753, R01 HL076784 and R01 AG028321.</p><p>Multi-Ethnic Study of Atherosclerosis (MESA) and the MESA SHARe project are conducted and supported by the NHLBI in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and CTSA UL1-RR-024156. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. This manuscript was not prepared in collaboration with MESA investigators and does not necessarily reflect the opinions or views of MESA, or the NHLBI.</p><p>The Health and Retirement Study (HRS) genetic data is sponsored by the Genetics Resource with HRS April 21, 2010, version G Page 5 of 7 National Institute on Aging (grant numbers U01AG009740, RC2AG036495, and RC4AG039029) and was conducted by the University of Michigan. This manuscript was not prepared in collaboration with HRS investigators and does not necessarily reflect the opinions or views of HRS, or the NHLBI.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST:</bold> The authors declare no conflicts of interest.</p></fn><fn fn-type="financial-disclosure"><p><bold>FUNDING:</bold> This research was supported by Grants No P01 AG043352 and R01AG047310 from the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This manuscript was prepared using a limited access datasets obtained though dbGaP (accession numbers: phs000007.v22.p10 (FHS), phs000280.v3.p1 (ARIC), phs000209.v13.p3 (MESA), phs000287.v5.p1 (CHS), phs000428.v1.p1 (HRS)). Phenotypic HRS data are available publicly and through restricted access from <ext-link ext-link-type="uri" xlink:href="http://hrsonline.isr.umich.edu/index.php?p=data">http://hrsonline.isr.umich.edu/index.php?p=data</ext-link>.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Button</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Ioannidis</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Mokrysz</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Nosek</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Flint</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Robinson</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Munaf&#242;</surname>
<given-names>MR</given-names></string-name>. <article-title>Power failure: why small sample size undermines the reliability of neuroscience.</article-title>
<source>Nat Rev Neurosci</source>. <year>2013</year>; <volume>14</volume>:<fpage>365</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3475</pub-id><?supplied-pmid 23571845?><pub-id pub-id-type="pmid">23571845</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Goddard</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Wray</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Visscher</surname>
<given-names>PM</given-names></string-name>. <article-title>Concepts, estimation and interpretation of SNP-based heritability.</article-title>
<source>Nat Genet</source>. <year>2017</year>; <volume>49</volume>:<fpage>1304</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3941</pub-id><?supplied-pmid 28854176?><pub-id pub-id-type="pmid">28854176</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Hamosh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Amberger</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Bocchini</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>McKusick</surname>
<given-names>VA</given-names></string-name>. <article-title>Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.</article-title>
<source>Nucleic Acids Res</source>. <year>2005</year>; <volume>33</volume>:<fpage>D514</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki033</pub-id><?supplied-pmid 15608251?><pub-id pub-id-type="pmid">15608251</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Plomin</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Haworth</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>OS</given-names></string-name>. <article-title>Common disorders are quantitative traits.</article-title>
<source>Nat Rev Genet</source>. <year>2009</year>; <volume>10</volume>:<fpage>872</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2670</pub-id><?supplied-pmid 19859063?><pub-id pub-id-type="pmid">19859063</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Lewontin</surname>
<given-names>RC</given-names></string-name>. <article-title>Annotation: the analysis of variance and the analysis of causes.</article-title>
<source>Am J Hum Genet</source>. <year>1974</year>; <volume>26</volume>:<fpage>400</fpage>&#8211;<lpage>11</lpage>.<?supplied-pmid 4827368?><pub-id pub-id-type="pmid">4827368</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Rose</surname>
<given-names>SP</given-names></string-name>. <article-title>Commentary: heritability estimates--long past their sell-by date.</article-title>
<source>Int J Epidemiol</source>. <year>2006</year>; <volume>35</volume>:<fpage>525</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyl064</pub-id><?supplied-pmid 16645027?><pub-id pub-id-type="pmid">16645027</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Nesse</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Ganten</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Gregory</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Omenn</surname>
<given-names>GS</given-names></string-name>. <article-title>Evolutionary molecular medicine.</article-title>
<source>J Mol Med (Berl)</source>. <year>2012</year>; <volume>90</volume>:<fpage>509</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-012-0889-9</pub-id><?supplied-pmid 22544168?><pub-id pub-id-type="pmid">22544168</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Kirkwood</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Cordell</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Finch</surname>
<given-names>CE</given-names></string-name>. <article-title>Speed-bumps ahead for the genetics of later-life diseases.</article-title>
<source>Trends Genet</source>. <year>2011</year>; <volume>27</volume>:<fpage>387</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2011.07.001</pub-id><?supplied-pmid 21824675?><pub-id pub-id-type="pmid">21824675</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Oeppen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vaupel</surname>
<given-names>JW</given-names></string-name>. <article-title>Demography. Broken limits to life expectancy.</article-title>
<source>Science</source>. <year>2002</year>; <volume>296</volume>:<fpage>1029</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1126/science.1069675</pub-id><?supplied-pmid 12004104?><pub-id pub-id-type="pmid">12004104</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Corella</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ordov&#225;s</surname>
<given-names>JM</given-names></string-name>. <article-title>Aging and cardiovascular diseases: the role of gene-diet interactions.</article-title>
<source>Ageing Res Rev</source>. <year>2014</year>; <volume>18</volume>:<fpage>53</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2014.08.002</pub-id><?supplied-pmid 25159268?><pub-id pub-id-type="pmid">25159268</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Kulminski</surname>
<given-names>AM</given-names></string-name>. <article-title>Unraveling genetic origin of aging-related traits: evolving concepts.</article-title>
<source>Rejuvenation Res</source>. <year>2013</year>; <volume>16</volume>:<fpage>304</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2013.1441</pub-id><?supplied-pmid 23768105?><pub-id pub-id-type="pmid">23768105</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Vijg</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Suh</surname>
<given-names>Y</given-names></string-name>. <article-title>Genetics of longevity and aging.</article-title>
<source>Annu Rev Med</source>. <year>2005</year>; <volume>56</volume>:<fpage>193</fpage>&#8211;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.med.56.082103.104617</pub-id><?supplied-pmid 15660509?><pub-id pub-id-type="pmid">15660509</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Crespi</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Stead</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Elliot</surname>
<given-names>M</given-names></string-name>. <article-title>Evolution in health and medicine Sackler colloquium: comparative genomics of autism and schizophrenia.</article-title>
<source>Proc Natl Acad Sci USA</source>. <year>2010</year> (<issue>Suppl 1</issue>); <volume>107</volume>:<fpage>1736</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0906080106</pub-id><?supplied-pmid 19955444?><pub-id pub-id-type="pmid">19955444</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Day-Williams</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Zeggini</surname>
<given-names>E</given-names></string-name>. <article-title>The effect of next-generation sequencing technology on complex trait research.</article-title>
<source>Eur J Clin Invest</source>. <year>2011</year>; <volume>41</volume>:<fpage>561</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2362.2010.02437.x</pub-id><?supplied-pmid 21155765?><pub-id pub-id-type="pmid">21155765</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Ukraintseva</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yashin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kulminski</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Akushevich</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Joshi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Land</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Stallard</surname>
<given-names>E</given-names></string-name>. <article-title>Puzzling role of genetic risk factors in human longevity: &#8220;risk alleles&#8221; as pro-longevity variants.</article-title>
<source>Biogerontology</source>. <year>2016</year>; <volume>17</volume>:<fpage>109</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-015-9600-1</pub-id><?supplied-pmid 26306600?><pub-id pub-id-type="pmid">26306600</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Kulminski</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kernogitski</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Culminskaya</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Loika</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Bagley</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Duan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Arbeeva</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ukraintseva</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stallard</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Yashin</surname>
<given-names>AI</given-names></string-name>. <article-title>Uncoupling associations of risk alleles with endophenotypes and phenotypes: insights from the ApoB locus and heart-related traits.</article-title>
<source>Aging Cell</source>. <year>2017</year>; <volume>16</volume>:<fpage>61</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12526</pub-id><?supplied-pmid 27683205?><pub-id pub-id-type="pmid">27683205</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Kulminski</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Raghavachari</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Culminskaya</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Arbeeva</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ukraintseva</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Christensen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yashin</surname>
<given-names>AI</given-names></string-name>. <article-title>Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study.</article-title>
<source>Biogerontology</source>. <year>2016</year>; <volume>17</volume>:<fpage>893</fpage>&#8211;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-016-9659-3</pub-id><?supplied-pmid 27447179?><pub-id pub-id-type="pmid">27447179</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Goh</surname>
<given-names>KI</given-names></string-name>, <string-name><surname>Cusick</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Valle</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Childs</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Vidal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barab&#225;si</surname>
<given-names>AL</given-names></string-name>. <article-title>The human disease network.</article-title>
<source>Proc Natl Acad Sci USA</source>. <year>2007</year>; <volume>104</volume>:<fpage>8685</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0701361104</pub-id><?supplied-pmid 17502601?><pub-id pub-id-type="pmid">17502601</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Kulminski</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>He</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Culminskaya</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Loika</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kernogitski</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Loiko</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Arbeeva</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bagley</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Duan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yashkin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Kovtun</surname>
<given-names>M</given-names></string-name>, <etal>et al</etal>
<article-title>Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality.</article-title>
<source>PLoS Genet</source>. <year>2016</year>; <volume>12</volume>:<fpage>e1006314</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006314</pub-id><?supplied-pmid 27832070?><pub-id pub-id-type="pmid">27832070</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Barab&#225;si</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Gulbahce</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Loscalzo</surname>
<given-names>J</given-names></string-name>. <article-title>Network medicine: a network-based approach to human disease.</article-title>
<source>Nat Rev Genet</source>. <year>2011</year>; <volume>12</volume>:<fpage>56</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2918</pub-id><?supplied-pmid 21164525?><pub-id pub-id-type="pmid">21164525</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Purcell</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Neale</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Todd-Brown</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Bender</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Maller</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sklar</surname>
<given-names>P</given-names></string-name>, <string-name><surname>de Bakker</surname>
<given-names>PI</given-names></string-name>, <string-name><surname>Daly</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Sham</surname>
<given-names>PC</given-names></string-name>. <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title>
<source>Am J Hum Genet</source>. <year>2007</year>; <volume>81</volume>:<fpage>559</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1086/519795</pub-id><?supplied-pmid 17701901?><pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Teslovich</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Musunuru</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Edmondson</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Stylianou</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Koseki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pirruccello</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Ripatti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chasman</surname>
<given-names>DI</given-names></string-name>, <string-name><surname>Willer</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Johansen</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Fouchier</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Isaacs</surname>
<given-names>A</given-names></string-name>, <etal>et al</etal>
<article-title>Biological, clinical and population relevance of 95 loci for blood lipids.</article-title>
<source>Nature</source>. <year>2010</year>; <volume>466</volume>:<fpage>707</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/nature09270</pub-id><?supplied-pmid 20686565?><pub-id pub-id-type="pmid">20686565</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Kulminski</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Loika</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Culminskaya</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Ukraintseva</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Stallard</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Yashin</surname>
<given-names>AI</given-names></string-name>. <article-title>Explicating heterogeneity of complex traits has strong potential for improving GWAS efficiency.</article-title>
<source>Sci Rep</source>. <year>2016</year>; <volume>6</volume>:<fpage>35390</fpage>. <pub-id pub-id-type="doi">10.1038/srep35390</pub-id><?supplied-pmid 27739495?><pub-id pub-id-type="pmid">27739495</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Sherman</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Lempicki</surname>
<given-names>RA</given-names></string-name>. <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.</article-title>
<source>Nat Protoc</source>. <year>2009</year>; <volume>4</volume>:<fpage>44</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><?supplied-pmid 19131956?><pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Welter</surname>
<given-names>D</given-names></string-name>, <string-name><surname>MacArthur</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Morales</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Burdett</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Junkins</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Klemm</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Flicek</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Manolio</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hindorff</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Parkinson</surname>
<given-names>H</given-names></string-name>. <article-title>The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.</article-title>
<source>Nucleic Acids Res</source>. <year>2014</year>; <volume>42</volume>:<fpage>D1001</fpage>&#8211;<lpage>06</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1229</pub-id><?supplied-pmid 24316577?><pub-id pub-id-type="pmid">24316577</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Maher</surname>
<given-names>B</given-names></string-name>. <article-title>Personal genomes: the case of the missing heritability.</article-title>
<source>Nature</source>. <year>2008</year>; <volume>456</volume>:<fpage>18</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/456018a</pub-id><?supplied-pmid 18987709?><pub-id pub-id-type="pmid">18987709</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Goldstein</surname>
<given-names>DB</given-names></string-name>. <article-title>Common genetic variation and human traits.</article-title>
<source>N Engl J Med</source>. <year>2009</year>; <volume>360</volume>:<fpage>1696</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMp0806284</pub-id><?supplied-pmid 19369660?><pub-id pub-id-type="pmid">19369660</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Franceschi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Garagnani</surname>
<given-names>P</given-names></string-name>. <article-title>Suggestions from Geroscience for the Genetics of Age-Related Diseases.</article-title>
<source>PLoS Genet</source>. <year>2016</year>; <volume>12</volume>:<fpage>e1006399</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006399</pub-id><?supplied-pmid 27832069?><pub-id pub-id-type="pmid">27832069</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Franco</surname>
<given-names>OH</given-names></string-name>, <string-name><surname>Karnik</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Osborne</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ordovas</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Catt</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van der Ouderaa</surname>
<given-names>F</given-names></string-name>. <article-title>Changing course in ageing research: the healthy ageing phenotype.</article-title>
<source>Maturitas</source>. <year>2009</year>; <volume>63</volume>:<fpage>13</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.maturitas.2009.02.006</pub-id><?supplied-pmid 19282116?><pub-id pub-id-type="pmid">19282116</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Kaeberlein</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rabinovitch</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>GM</given-names></string-name>. <article-title>Healthy aging: the ultimate preventative medicine.</article-title>
<source>Science</source>. <year>2015</year>; <volume>350</volume>:<fpage>1191</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad3267</pub-id><?supplied-pmid 26785476?><pub-id pub-id-type="pmid">26785476</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Guarente</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Franklin</surname>
<given-names>H</given-names></string-name>. <article-title>Franklin H. Epstein Lecture: Sirtuins, aging, and medicine.</article-title>
<source>N Engl J Med</source>. <year>2011</year>; <volume>364</volume>:<fpage>2235</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1100831</pub-id><?supplied-pmid 21651395?><pub-id pub-id-type="pmid">21651395</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Zhavoronkov</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Moskalev</surname>
<given-names>A</given-names></string-name>. <article-title>Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives.</article-title>
<source>Front Genet</source>. <year>2016</year>; <volume>7</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2016.00017</pub-id><?supplied-pmid 26909101?><pub-id pub-id-type="pmid">26909101</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Schork</surname>
<given-names>NJ</given-names></string-name>. <article-title>Personalized medicine: time for one-person trials.</article-title>
<source>Nature</source>. <year>2015</year>; <volume>520</volume>:<fpage>609</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/520609a</pub-id><?supplied-pmid 25925459?><pub-id pub-id-type="pmid">25925459</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Jazwinski</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bi</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Arnold</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Batzer</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Welsh</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Lefante</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Volaufova</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Myers</surname>
<given-names>L</given-names></string-name>, <etal>et al</etal> and <collab>Georgia Centenarian Study and the Louisiana Healthy Aging Study</collab>. <article-title>HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging.</article-title>
<source>Aging Cell</source>. <year>2010</year>; <volume>9</volume>:<fpage>698</fpage>&#8211;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00600.x</pub-id><?supplied-pmid 20569235?><pub-id pub-id-type="pmid">20569235</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Spreckley</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>KG</given-names></string-name>. <article-title>The L-Cell in Nutritional Sensing and the Regulation of Appetite.</article-title>
<source>Front Nutr</source>. <year>2015</year>; <volume>2</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2015.00023</pub-id><?supplied-pmid 26258126?><pub-id pub-id-type="pmid">26258126</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Reimann</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tolhurst</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gribble</surname>
<given-names>FM</given-names></string-name>. <article-title>G-protein-coupled receptors in intestinal chemosensation.</article-title>
<source>Cell Metab</source>. <year>2012</year>; <volume>15</volume>:<fpage>421</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2011.12.019</pub-id><?supplied-pmid 22482725?><pub-id pub-id-type="pmid">22482725</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Zalewska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Siara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sajewicz</surname>
<given-names>W</given-names></string-name>. <article-title>G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy.</article-title>
<source>Acta Pol Pharm</source>. <year>2014</year>; <volume>71</volume>:<fpage>229</fpage>&#8211;<lpage>43</lpage>.<?supplied-pmid 25272642?><pub-id pub-id-type="pmid">25272642</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Sch&#246;neberg</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Schulz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Biebermann</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hermsdorf</surname>
<given-names>T</given-names></string-name>, <string-name><surname>R&#246;mpler</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sangkuhl</surname>
<given-names>K</given-names></string-name>. <article-title>Mutant G-protein-coupled receptors as a cause of human diseases.</article-title>
<source>Pharmacol Ther</source>. <year>2004</year>; <volume>104</volume>:<fpage>173</fpage>&#8211;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2004.08.008</pub-id><?supplied-pmid 15556674?><pub-id pub-id-type="pmid">15556674</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Serezani</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Ballinger</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Aronoff</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Peters-Golden</surname>
<given-names>M</given-names></string-name>. <article-title>Cyclic AMP: master regulator of innate immune cell function.</article-title>
<source>Am J Respir Cell Mol Biol</source>. <year>2008</year>; <volume>39</volume>:<fpage>127</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2008-0091TR</pub-id><?supplied-pmid 18323530?><pub-id pub-id-type="pmid">18323530</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Sharrett</surname>
<given-names>AR</given-names></string-name>. <article-title>The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component.</article-title>
<source>Ann Epidemiol</source>. <year>1992</year>; <volume>2</volume>:<fpage>467</fpage>&#8211;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/1047-2797(92)90096-9</pub-id><?supplied-pmid 1342297?><pub-id pub-id-type="pmid">1342297</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Investigators</surname>
<given-names>TA</given-names></string-name>. <article-title>The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.</article-title>
<source>Am J Epidemiol</source>. <year>1989</year>; <volume>129</volume>:<fpage>687</fpage>&#8211;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a115184</pub-id><?supplied-pmid 2646917?><pub-id pub-id-type="pmid">2646917</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Fried</surname>
<given-names>LP</given-names></string-name>, <string-name><surname>Borhani</surname>
<given-names>NO</given-names></string-name>, <string-name><surname>Enright</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Furberg</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Gardin</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Kronmal</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Kuller</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Manolio</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Mittelmark</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Newman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>O&#8217;Leary</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Psaty</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Rautaharju</surname>
<given-names>P</given-names></string-name>, <etal>et al</etal>
<article-title>The Cardiovascular Health Study: design and rationale.</article-title>
<source>Ann Epidemiol</source>. <year>1991</year>; <volume>1</volume>:<fpage>263</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/1047-2797(91)90005-W</pub-id><?supplied-pmid 1669507?><pub-id pub-id-type="pmid">1669507</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Bild</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Bluemke</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Burke</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Detrano</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Diez Roux</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Folsom</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Greenland</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Jacob</surname>
<given-names>DR</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Kronmal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>O&#8217;Leary</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Saad</surname>
<given-names>MF</given-names></string-name>, <etal>et al</etal>
<article-title>Multi-Ethnic Study of Atherosclerosis: objectives and design.</article-title>
<source>Am J Epidemiol</source>. <year>2002</year>; <volume>156</volume>:<fpage>871</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwf113</pub-id><?supplied-pmid 12397006?><pub-id pub-id-type="pmid">12397006</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Govindaraju</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Cupples</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Kannel</surname>
<given-names>WB</given-names></string-name>, <string-name><surname>O&#8217;Donnell</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Atwood</surname>
<given-names>LD</given-names></string-name>, <string-name><surname>D&#8217;Agostino</surname>
<given-names>RB</given-names>
<suffix>Sr</suffix></string-name>, <string-name><surname>Fox</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Larson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Levy</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Murabito</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vasan</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Splansky</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Wolf</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Benjamin</surname>
<given-names>EJ</given-names></string-name>. <article-title>Genetics of the Framingham Heart Study population.</article-title>
<source>Adv Genet</source>. <year>2008</year>; <volume>62</volume>:<fpage>33</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-2660(08)00602-0</pub-id><?supplied-pmid 19010253?><pub-id pub-id-type="pmid">19010253</pub-id></mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>Splansky</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Corey</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Atwood</surname>
<given-names>LD</given-names></string-name>, <string-name><surname>Cupples</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Benjamin</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>D&#8217;Agostino</surname>
<given-names>RB</given-names>
<suffix>Sr</suffix></string-name>, <string-name><surname>Fox</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Larson</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Murabito</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>O&#8217;Donnell</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Vasan</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Wolf</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Levy</surname>
<given-names>D</given-names></string-name>. <article-title>The Third Generation Cohort of the National Heart, Lung, and Blood Institute&#8217;s Framingham Heart Study: design, recruitment, and initial examination.</article-title>
<source>Am J Epidemiol</source>. <year>2007</year>; <volume>165</volume>:<fpage>1328</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwm021</pub-id><?supplied-pmid 17372189?><pub-id pub-id-type="pmid">17372189</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>Cupples</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Heard-Costa</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atwood</surname>
<given-names>LD</given-names></string-name>, and <collab>Framingham Heart Study Investigators</collab>. <article-title>Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data.</article-title>
<source>BMC Proc</source>. <year>2009</year> (<issue>Suppl 7</issue>); <volume>3</volume>:<fpage>S3</fpage>. <pub-id pub-id-type="doi">10.1186/1753-6561-3-s7-s3</pub-id><?supplied-pmid 20018020?><pub-id pub-id-type="pmid">20018020</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Juster</surname>
<given-names>FT</given-names></string-name>, <string-name><surname>Suzman</surname>
<given-names>R</given-names></string-name>. <article-title>An overview of the health and retirement study.</article-title>
<source>J Hum Resour</source>. <year>1995</year>; <volume>30</volume>:<fpage>S7</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.2307/146277</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>Howie</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Donnelly</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Marchini</surname>
<given-names>J</given-names></string-name>. <article-title>A flexible and accurate genotype imputation method for the next generation of genome-wide association studies.</article-title>
<source>PLoS Genet</source>. <year>2009</year>; <volume>5</volume>:<fpage>e1000529</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000529</pub-id><?supplied-pmid 19543373?><pub-id pub-id-type="pmid">19543373</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="book">Fisher RA. 1970. Statistical methods for research workers. (Edinburgh: Oliver and Boyd).</mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><string-name><surname>Shi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Rice</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Gu</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Rao</surname>
<given-names>DC</given-names></string-name>. <article-title>Application of three-level linear mixed-effects model incorporating gene-age interactions for association analysis of longitudinal family data.</article-title>
<source>BMC Proc</source>. <year>2009</year> (<issue>Suppl 7</issue>); <volume>3</volume>:<fpage>S89</fpage>. <pub-id pub-id-type="doi">10.1186/1753-6561-3-s7-s89</pub-id><?supplied-pmid 20018085?><pub-id pub-id-type="pmid">20018085</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><string-name><surname>Bates</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Machler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bolker</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>SC</given-names></string-name>. <article-title>Fitting Linear Mixed-Effects Models Using lme4.</article-title>
<source>J Stat Softw</source>. <year>2015</year>; <volume>67</volume>:<fpage>1</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><string-name><surname>Prentice</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Breslow</surname>
<given-names>N</given-names></string-name>. <article-title>Retrospective studies and failure time models.</article-title>
<source>Biometrika</source>. <year>1978</year>; <volume>65</volume>:<fpage>153</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1093/biomet/65.1.153</pub-id></mixed-citation></ref><ref id="r53"><label>53</label><mixed-citation publication-type="journal"><string-name><surname>Ikram</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Seshadri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bis</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Fornage</surname>
<given-names>M</given-names></string-name>, <string-name><surname>DeStefano</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Aulchenko</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Debette</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lumley</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Folsom</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>van den Herik</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>Bos</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Beiser</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cushman</surname>
<given-names>M</given-names></string-name>, <etal>et al</etal>
<article-title>Genomewide association studies of stroke.</article-title>
<source>N Engl J Med</source>. <year>2009</year>; <volume>360</volume>:<fpage>1718</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0900094</pub-id><?supplied-pmid 19369658?><pub-id pub-id-type="pmid">19369658</pub-id></mixed-citation></ref><ref id="r54"><label>54</label><mixed-citation publication-type="journal"><string-name><surname>Yashin</surname>
<given-names>AI</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Arbeev</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Arbeeva</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Akushevich</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Kulminski</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Culminskaya</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Stallard</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ukraintseva</surname>
<given-names>SV</given-names></string-name>. <article-title>Genetic Structures of Population Cohorts Change with Increasing Age: Implications for Genetic Analyses of Human aging and Life Span.</article-title>
<source>Ann Gerontol Geriatr Res</source>. <year>2014</year>; <volume>1</volume>.<?supplied-pmid 25893220?><pub-id pub-id-type="pmid">25893220</pub-id></mixed-citation></ref><ref id="r55"><label>55</label><mixed-citation publication-type="journal"><string-name><surname>Willer</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Abecasis</surname>
<given-names>GR</given-names></string-name>. <article-title>METAL: fast and efficient meta-analysis of genomewide association scans.</article-title>
<source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>:<fpage>2190</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq340</pub-id><?supplied-pmid 20616382?><pub-id pub-id-type="pmid">20616382</pub-id></mixed-citation></ref><ref id="r56"><label>56</label><mixed-citation publication-type="journal"><string-name><surname>Begum</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ghosh</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Tseng</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Feingold</surname>
<given-names>E</given-names></string-name>. <article-title>Comprehensive literature review and statistical considerations for GWAS meta-analysis.</article-title>
<source>Nucleic Acids Res</source>. <year>2012</year>; <volume>40</volume>:<fpage>3777</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr1255</pub-id><?supplied-pmid 22241776?><pub-id pub-id-type="pmid">22241776</pub-id></mixed-citation></ref><ref id="r57"><label>57</label><mixed-citation publication-type="journal"><string-name><surname>Fortney</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Dobriban</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Garagnani</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pirazzini</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Monti</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mari</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Atzmon</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Barzilai</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Franceschi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Owen</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>SK</given-names></string-name>. <article-title>Genome-Wide Scan Informed by Age-Related Disease Identifies Loci for Exceptional Human Longevity.</article-title>
<source>PLoS Genet</source>. <year>2015</year>; <volume>11</volume>:<fpage>e1005728</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005728</pub-id><?supplied-pmid 26677855?><pub-id pub-id-type="pmid">26677855</pub-id></mixed-citation></ref><ref id="r58"><label>58</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>LJ</given-names></string-name>. <article-title>Combining dependent tests for linkage or association across multiple phenotypic traits.</article-title>
<source>Biostatistics</source>. <year>2003</year>; <volume>4</volume>:<fpage>223</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1093/biostatistics/4.2.223</pub-id><?supplied-pmid 12925518?><pub-id pub-id-type="pmid">12925518</pub-id></mixed-citation></ref><ref id="r59"><label>59</label><mixed-citation publication-type="journal"><string-name><surname>Bolormaa</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pryce</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Reverter</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Barendse</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kemper</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tier</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Savin</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hayes</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Goddard</surname>
<given-names>ME</given-names></string-name>. <article-title>A multi-trait, meta-analysis for detecting pleiotropic polymorphisms for stature, fatness and reproduction in beef cattle.</article-title>
<source>PLoS Genet</source>. <year>2014</year>; <volume>10</volume>:<fpage>e1004198</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1004198</pub-id><?supplied-pmid 24675618?><pub-id pub-id-type="pmid">24675618</pub-id></mixed-citation></ref><ref id="r60"><label>60</label><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tayo</surname>
<given-names>BO</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Franceschini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Yanek</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>YV</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Nalls</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>E</given-names></string-name>, <etal>et al</etal> and <collab>COGENT BP Consortium</collab>. <article-title>Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension.</article-title>
<source>Am J Hum Genet</source>. <year>2015</year>; <volume>96</volume>:<fpage>21</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.11.011</pub-id><?supplied-pmid 25500260?><pub-id pub-id-type="pmid">25500260</pub-id></mixed-citation></ref><ref id="r61"><label>61</label><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tayo</surname>
<given-names>BO</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Franceschini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Yanek</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>YV</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Nalls</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>E</given-names></string-name>, <etal>et al</etal> and <collab>COGENT BP Consortium</collab>. <article-title>Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension.</article-title>
<source>Am J Hum Genet</source>. <year>2015</year>; <volume>96</volume>:<fpage>21</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.11.011</pub-id><?supplied-pmid 25500260?><pub-id pub-id-type="pmid">25500260</pub-id></mixed-citation></ref><ref id="r62"><label>62</label><mixed-citation publication-type="journal"><string-name><surname>Leslie</surname>
<given-names>R</given-names></string-name>, <string-name><surname>O&#8217;Donnell</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>AD</given-names></string-name>. <article-title>GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database.</article-title>
<source>Bioinformatics</source>. <year>2014</year>; <volume>30</volume>:<fpage>i185</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu273</pub-id><?supplied-pmid 24931982?><pub-id pub-id-type="pmid">24931982</pub-id></mixed-citation></ref></ref-list></back></article>